Swiss National Bank Reduces Stock Position in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Swiss National Bank lessened its stake in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTAFree Report) by 10.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 33,000 shares of the company’s stock after selling 3,800 shares during the quarter. Swiss National Bank owned approximately 0.13% of Establishment Labs worth $854,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Fourth Sail Capital LP purchased a new stake in Establishment Labs during the 4th quarter worth about $14,473,000. CWM LLC boosted its stake in Establishment Labs by 95.8% in the 4th quarter. CWM LLC now owns 146,071 shares of the company’s stock worth $3,782,000 after buying an additional 71,459 shares during the last quarter. Kornitzer Capital Management Inc. KS boosted its stake in Establishment Labs by 26.3% in the 4th quarter. Kornitzer Capital Management Inc. KS now owns 389,160 shares of the company’s stock worth $10,075,000 after buying an additional 81,155 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Establishment Labs by 67.2% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,591 shares of the company’s stock worth $119,000 after buying an additional 1,845 shares during the last quarter. Finally, Assenagon Asset Management S.A. boosted its stake in Establishment Labs by 357.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 30,247 shares of the company’s stock worth $783,000 after buying an additional 23,639 shares during the last quarter. Hedge funds and other institutional investors own 72.91% of the company’s stock.

Establishment Labs Stock Performance

Establishment Labs stock opened at $52.23 on Friday. The stock’s 50 day moving average price is $52.37 and its 200 day moving average price is $40.27. The firm has a market capitalization of $1.44 billion, a PE ratio of -16.63 and a beta of 1.23. The company has a debt-to-equity ratio of 3.38, a quick ratio of 2.73 and a current ratio of 4.24. Establishment Labs Holdings Inc. has a one year low of $16.96 and a one year high of $73.00.

Establishment Labs (NASDAQ:ESTAGet Free Report) last released its quarterly earnings results on Wednesday, May 8th. The company reported ($0.58) EPS for the quarter, topping the consensus estimate of ($0.65) by $0.07. Establishment Labs had a negative return on equity of 206.05% and a negative net margin of 53.12%. The firm had revenue of $37.17 million for the quarter, compared to analyst estimates of $35.61 million. During the same period in the previous year, the company posted ($0.48) EPS. Establishment Labs’s revenue for the quarter was down 20.1% on a year-over-year basis. As a group, sell-side analysts expect that Establishment Labs Holdings Inc. will post -1.73 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts have issued reports on ESTA shares. Citigroup lowered Establishment Labs from a “buy” rating to a “neutral” rating and set a $60.00 price target on the stock. in a research note on Wednesday, May 22nd. Mizuho lifted their price objective on Establishment Labs from $50.00 to $65.00 and gave the company a “buy” rating in a research note on Monday, April 1st. Finally, JPMorgan Chase & Co. boosted their price target on Establishment Labs from $46.00 to $53.00 and gave the stock an “overweight” rating in a research report on Thursday, February 29th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $55.00.

Check Out Our Latest Research Report on Establishment Labs

Establishment Labs Profile

(Free Report)

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.

See Also

Want to see what other hedge funds are holding ESTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Establishment Labs Holdings Inc. (NASDAQ:ESTAFree Report).

Institutional Ownership by Quarter for Establishment Labs (NASDAQ:ESTA)

Receive News & Ratings for Establishment Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Establishment Labs and related companies with MarketBeat.com's FREE daily email newsletter.